*  Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer did not Improve Angiographic Outcomes Compared to Everolimus-Eluting...
Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer did not Improve Angiographic Outcomes Compared to Everolimus-Eluting ... ultra-thin strut sirolimus-eluting stents (Osiro SES) with a biodegradable polymer compared to thin-strut everolimus-eluting ... with successfully recanalized native total or chronic total coronary occlusions were randomized to the hybrid sirolimus-eluting ...
  http://www.crf.org/crf/news-and-events/news/news/1866-hybrid-sirolimus-eluting-stents-with-biodegradable-polymer-did-not-improve-angiographic-outcomes-compared-to-everolimus-eluting-stents-with-durable-polymer
*  Patent US5985890 - Rapamycin derivatives - Google Patents
Methods and kits for the determination of sirolimus in a sample. US20060121545 *. Nov 14, 2005. Jun 8, 2006. Wyeth. Rapamycin ... Methods and kits for the determination of sirolimus in a sample. US8088789. Mar 11, 2008. Jan 3, 2012. Elixir Medical ... Compositions and methods for detection of sirolimus. US7196192. Sep 19, 2005. Mar 27, 2007. Ariad Gene Therapeutics, Inc.. 28- ... Compositions and methods for detection of sirolimus. US20070117833 *. Nov 30, 2004. May 24, 2007. Maibuecher Axel. ...
  http://www.google.com/patents/US5985890?dq=5920316
*  Abstract 4916: Difference in Neointimal Growth on the Stent Struts Crossing a Side Branch Between Sirolimus-Eluting Stent and...
We examined differences in neointimal growth on the stent struts crossing a side branch between sirolimus-eluting stent (SES) ... Abstract 4916: Difference in Neointimal Growth on the Stent Struts Crossing a Side Branch Between Sirolimus-Eluting Stent and ... Abstract 4916: Difference in Neointimal Growth on the Stent Struts Crossing a Side Branch Between Sirolimus-Eluting Stent and ... Abstract 4916: Difference in Neointimal Growth on the Stent Struts Crossing a Side Branch Between Sirolimus-Eluting Stent and ...
  http://circ.ahajournals.org/content/118/Suppl_18/S_960.1
*  Abstract 2159: Medial Necrosis Due to Sirolimus-Eluting Stent Implantation in Human Coronary Arteries | Circulation
Background: Sirolimus-eluting stents (SES) have been proven to reduce the rates of restenosis by a striking inhibition of ... Abstract 2159: Medial Necrosis Due to Sirolimus-Eluting Stent Implantation in Human Coronary Arteries. Katsumi Inoue, Kazuaki ... The cytostatic effects of sirolimus on neointimal formation could be complicated by these local cytotoxic effects followed by a ... Abstract 2159: Medial Necrosis Due to Sirolimus-Eluting Stent Implantation in Human Coronary Arteries ...
  http://circ.ahajournals.org/content/116/Suppl_16/II_468.3
*  lymphedema from sirolimus treatment [Lymphedema People]
Lymphedema From Sirolimus Treatment. Sirolimus (INN) is a relatively new immunosuppressant drug used to prevent rejection in ... 8) Gelder et al hypothesized that the antiproliferative effect of sirolimus combined with the effect of sirolimus on growth ... sirolimus, steroids, and basiliximab. Following the protocol, after one month, the patient was randomized to the "sirolimus ... Limb lymphedema in sirolimus-treated patients. Transplant Proc. 2007 May Al-Otaibi T, Ahamed N, Nampoory MR, Al-Kandari N, Nair ...
  http://www.lymphedemapeople.com/wiki/doku.php?id=lymphedema_from_sirolimus_treatment
*  Clinical Evaluation of a Bioresorbable Sirolimus-eluting Coronary Scaffold in the Treatment of Patients With Denovo Coronary...
... efficacy and safety of NeoVas sirolimus-eluting bioresorbable coronary scaffold versus XIENCE PRIME ... Clinical Evaluation of a Bioresorbable Sirolimus-eluting Coronary Scaffold in the Treatment of Patients With Denovo Coronary ... Clinical Evaluation of a Bioresorbable Sirolimus-eluting Coronary Scaffold in the Treatment of Patients With Denovo Coronary ...
  http://adisinsight.springer.com/trials/700252084?error=cookies_not_supported&code=50bbfbbb-f5e1-404b-9645-ea56de35a30a
*  The Representative Porcine Model for Human Cardiovascular Disease : Figure 5
Cypher sirolimus-eluting stents (SESs), Taxus paclitaxel-eluting stents (PESs), and Driver bare metal stents (BMSs) in rabbit ...
  https://www.hindawi.com/journals/bmri/2011/195483/fig5/
*  China Sirolimus Eluting Coronary Stent - China Sirolimus Eluting Coronary Stent, Drug Eluting Stent
Find details about China Sirolimus Eluting Coronary Stent, Drug Eluting Stent from Sirolimus Eluting Coronary Stent - Yilson ... coating process allows the integrity of coated polymer after excessive stent expansion and a systemic elution of sirolimus in a ...
  http://yilson.en.made-in-china.com/product/zqBQYwIlrehy/China-Sirolimus-Eluting-Coronary-Stent.html
*  Cordis Announces Discontinuation of NEVOâ„¢ Sirolimus-Eluting Coronary Stent
... Wed, 06/15/2011 - 6:33am Comments by Bio-Medicine ... The company will also stop the manufacture of CYPHER® and CYPHER SELECT® Plus Sirolimus-Eluting Coronary Stents by the end of ... Sirolimus-Eluting Coronary Stent in order to focus on other cardiovascular therapies where significant patient need exists. ...
  https://www.mdtmag.com/news/2011/06/cordis-announces-discontinuation-nevo%C3%A2%E2%80%9E%C2%A2-sirolimus-eluting-coronary-stent
*  Randomized Study Comparing Endeavor With Cypher Stents (PROTECT) - Full Text View - ClinicalTrials.gov
Sirolimus. Anti-Bacterial Agents. Anti-Infective Agents. Antibiotics, Antineoplastic. Antineoplastic Agents. Antifungal Agents ... Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent ... Medtronic Endeavor® Zotarolimus Eluting Coronary Stent System or next generation model Cordis Cypher® Sirolimus-eluting ... Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus- ...
  https://clinicaltrials.gov/ct2/show/NCT00476957?term=heart+attack&lup_s=04%2F22%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14
*  An Observational Safety Evaluation of Patients Treated With the NEVO Sirolimus-eluting Coronary Stent. - AdisInsight
This head-to-head trial will assess the non-inferiority of NEVO sirolimus-eluting stent to the XIENCE V everolimus-eluting ... An Observational Safety Evaluation of Patients Treated With the NEVO Sirolimus-eluting Coronary Stent. Next Previous ... An Observational Safety Evaluation of Patients Treated With the NEVO Sirolimus-eluting Coronary Stent. Discontinued ...
  http://adisinsight.springer.com/trials/700043106?error=cookies_not_supported&code=34894da3-1300-4a91-8a3e-d6580074d5b2
*  Preliminary Results of the Hydroxyapatite Nonpolymer-Based Sirolimus-Eluting Stent for the Treatment of Single De Novo Coronary...
Antiproliferative agent sirolimus. Sirolimus (Rapamune), a natural macrocyclic lactone, is a potent immunosuppressive agent ... Regarding sirolimus kinetics in the VES, in vitro testing on crimped and expanded stents at 37°C in 7.4 pH buffered saline ... The main finding of this first-in-human study with the non-polymer-based VES is that sirolimus can be efficiently delivered to ... In this context, the novel VES carries less than one-half of the dose of the first-generation Cypher sirolimus-eluting stent. ...
  http://interventions.onlinejacc.org/content/1/5/545
*  Sirolimus - Wikipedia
Sirolimus seems to lower the cancer risk in some transplant patients. Sirolimus was shown to inhibit the progression of dermal ... Sirolimus blocks this pathway. The safety and efficacy of sirolimus treatment of LAM were investigated in clinical trials that ... The antiproliferative effects of sirolimus may have a role in treating cancer. When dosed appropriately, sirolimus can enhance ... and Tor2 as the targets of sirolimus and provided robust support that the FKBP12-sirolimus complex binds to and inhibits Tor1 ...
  https://en.wikipedia.org/wiki/Sirolimus
*  Sirolimus | LabCorp
Is sirolimus given to patients who receive organs other than kidneys or have other conditions?. Sirolimus also is used ... Where are sirolimus tests performed?. Sirolimus tests may be performed in a local hospital laboratory but may also be sent to a ... How long will I need to be on sirolimus?. Transplant recipients must take immunosuppressants - including sirolimus or other ... Who orders sirolimus tests?. Sirolimus will usually be monitored by the healthcare provider and transplant team that performed ...
  https://www.labcorp.com/help/patient-test-info/sirolimus
*  Sirolimus
SOURCE: Sirolimus ( ) Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information. Copyright ... Sirolimus can lower the number of your white blood cells, red blood cells and platelets. You may be at an increased risk for ... Sirolimus may be taken with or without food. Taking it with food will decrease stomach upset. Be consistent, if you take it ... When having sirolimus blood levels drawn, do not take the morning dose of medication until after your blood sample is taken. ...
  http://www.transplant.bc.ca/transplant-and-medications/anti-rejection-medication/sirolimus
*  Sirolimus - wikidoc
Sirolimus. Revision as of 20:01, 27 September 2011 by WikiBot. (talk , contribs) (Protected 'Sirolimus': Protecting pages from ... The anti-proliferative effects of sirolimus may have a role in treating cancer. Recently, it was shown that sirolimus inhibited ... Sirolimus is a macrolide ("-mycin") first discovered as a product of the bacterium Streptomyces hygroscopicus in a soil sample ... The mode of action of sirolimus is to bind the cytosolic protein FK-binding protein 12 (FKBP12) in a manner similar to ...
  http://wikidoc.org/index.php?title=Sirolimus&oldid=607157
*  Sirolimus Tablets: Indications, Side Effects, Warnings - Drugs.com
Easy to read patient leaflet for Sirolimus Tablets. Includes indications, proper use, special instructions, precautions, and ... What do I need to tell my doctor BEFORE I take Sirolimus Tablets?. *If you have an allergy to sirolimus or any other part of ... Sirolimus Tablets. Generic Name: Sirolimus Tablets (sir OH li mus). Brand Name: Rapamune ... How is this medicine (Sirolimus Tablets) best taken?. Use this medicine (sirolimus tablets) as ordered by your doctor. Read all ...
  https://www.drugs.com/cdi/sirolimus-tablets.html
*  Sirolimus | Springer for Research & Development
Feng QZ, Wang SW, Zhao YS, Zheng XQ.Subacute stent thrombosis happening at discharge. International Journal of Cardiology 119: E59-E62, No. 2, 10 Jun 2007 - ChinaGoogle Scholar ...
  https://rd.springer.com/article/10.2165/00128415-200711730-00071
*  Sirolimus for Massive Polycystic Liver - Full Text View - ClinicalTrials.gov
Among them, octreotide and sirolimus have been shown to be one of the most promising drugs to reduce cyst volume. Sirolimus ... Experimental: Sirolimus Sirolimus administration group starting dose: 2mg/day target trough level: 4-10 ng/dL ... Drug: Sirolimus Sirolimus administration for 12 months followed by conventional therapy alone for additional 12 months ... Sirolimus for Massive Polycystic Liver (SILVER). The recruitment status of this study is unknown. The completion date has ...
  https://clinicaltrials.gov/ct2/show/NCT01680250?recr=Open&cond=%22Polycystic+Kidney+Diseases%22&rank=13
*  Sirolimus Prices and Sirolimus Coupons - GoodRx
Compare prices and print coupons for Sirolimus (Rapamune) and other Organ Transplant drugs at CVS, Walgreens, and other ... Sirolimus Prices and Sirolimus Coupons - GoodRx', 'info_page': 'What is Sirolimus? - GoodRx', 'images_page': 'Sirolimus Images ... sirolimus', 'drug_description': ',a href='/sirolimus',SIROLIMUS,/a, is used to decrease the immune system's response to a ... Sirolimus - Savings Tips - GoodRx'}, 'header_title': ',a href=\'/sirolimus\',Sirolimus,/a,', 'form_slug': 'tablet', 'form': ' ...
  https://www.goodrx.com/sirolimus
*  Sirolimus as Therapeutic Approach to Uveitis - Full Text View - ClinicalTrials.gov
Drug: Sirolimus (rapamycin) Will receive subconjunctival injections of sirolimus 1320 µg in the study eye on Days 0, 60, and ... Drug: Sirolimus (rapamycin) Will receive intravitreal injections of sirolimus (rapamycin) 352 µg in study eye on Days 0, 60, ... Sirolimus as Therapeutic Approach to Uveitis (SAVE). The safety and scientific validity of this study is the responsibility of ... The purpose of this study is to find out about the safety and effectiveness of the study drug, sirolimus, in patients with ...
  https://clinicaltrials.gov/ct2/show/NCT00908466?cond=%22Pars+planitis%22&rank=6
*  Eyetube.net : Sirolimus for Chronic AMD
The study compared central subfield thickness data of patients who received monotherapy sirolimus versus those who continued ... reviews a study evaluating intravitreal sirolimus therapy for chronic age-related macular degeneration. ... Raj Maturi, MD, reviews a study evaluating intravitreal sirolimus therapy for chronic age-related macular degeneration. The ... study compared central subfield thickness data of patients who received monotherapy sirolimus versus those who continued with ...
  http://eyetube.net/series/daily-coverage-asrs-sanfrancisco-2016/ihodo/?sa=amd-disease-education
*  Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus
Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney ... A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and ... This study is being done to find out which treatment, tacrolimus or sirolimus, leads to better long-term kidney function. ... The purpose of this study is to compare treatment with the new drug sirolimus (SRL) versus the standard treatment with ...
  https://www.bioportfolio.com/resources/trial/69525/Comparison-of-Tacrolimus-and-Myfortic-Versus-Tacrolimus-and-Sirolimus.html